Histogen: Clinical Trials

2 trials sponsored by Histogen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 11Unknown 1

Follow Histogen: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
Emricasan, Placebo - Cirrhosis, Portal Hypertension
Phase 2CompletedHistogen2632016-10-172022-02-11
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
Hair Stimulating Complex (HSC), Dulbecco's Modified Eagle Medium, DMEM - Androgenetic Alopecia
Phase 1 / Phase 2UnknownHistogen562011-12-012012-01-18

Conditions studied

Alopecia (1)  ·  Fibrosis (1)  ·  Hypertension, Portal (1)  ·  Liver Cirrhosis (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Interventions

3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid (1)

Countries

Germany (1)  ·  Philippines (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Jeanette M Wetzel (1)  ·  Julieta P. Arambulo, MD (1)  ·  Ruqayyah Abdulrahoof (1)  ·  Samuel Mboggo (1)  ·  Theresa Marie Reyes-Cacas, MD (1)

Results publications

PMID 31870950